Literature DB >> 8590567

Functions of T-cell subsets and cytokines in mycobacterial infections.

M E Munk1, M Emoto.   

Abstract

Phagocytosed M. tuberculosis either multiply inside the endocytic compartment of mononuclear phagocytes or they are destroyed by the host cell. Due to this macrophage-shelter (ab)used by mycobacteria, tuberculosis is controlled by the cellular immune response. Protection against mycobacteria depends on alpha/beta T-cells expressing the CD4 or CD8 phenotype. T-cell-mediated immunity amplifies macrophage capacities to kill and digest the bacilli. Specific alpha/beta T-cells produce several cytokines that attract and activate macrophages and additional lymphocytes, such as: interferon-gamma (IFN-gamma) which has the capacity to activate several antimicrobial properties of macrophages; tumour necrosis factor-alpha (TNF-alpha) a key cytokine involved in granuloma formation; interleukins 2, 6 and 8 (IL-2; IL-6 and IL-8); and interleukin 12 (IL-12), a candidate cytokine for the induction of Th1 cells. Furthermore, CD4+ and CD8+ T-cells display cytotoxic activity, which permits them to control mycobacterial growth through destruction of the infected cells. Escaping bacteria are subsequently ingested and destroyed by surrounding macrophages activated by T-cells. There is evidence to associate gamma/delta T-cells with antimycobacterial immunity, such as their preferential accumulation in inflammatory lesions, in necrotic areas of tuberculous lymphadenitis, and potent in vitro stimulation by M. tuberculosis components. In addition, M. tuberculosis activated gamma/delta T-cells are cytolytic and secrete several cytokines. Hence, clinical tuberculosis is associated with T-cell reactivity which controls the local concentrations of tubercle bacilli. Taken together, the cellular response, cytokine regulation, and the definition of target molecules are important aspects for the understanding of pathological immune mechanisms in tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590567

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN: 0904-1850


  30 in total

1.  Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment.

Authors:  A Verbon; N Juffermans; S J Van Deventer; P Speelman; H Van Deutekom; T Van Der Poll
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas.

Authors:  Gael Fenhalls; Liesel Stevens; Juanita Bezuidenhout; Gillian E Amphlett; Ken Duncan; Philip Bardin; Pauline T Lukey
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile.

Authors:  B I Restrepo; J I Alvarez; J A Castaño; L F Arias; M Restrepo; J Trujillo; C H Colegial; J M Teale
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha.

Authors:  F G Imperiali; A Zaninoni; L La Maestra; P Tarsia; F Blasi; W Barcellini
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 5.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

6.  Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis.

Authors:  K M Drescher; L T Nguyen; V Taneja; M J Coenen; J L Leibowitz; G Strauss; G J Hammerling; C S David; M Rodriguez
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Gene expression profiling of peripheral blood mononuclear cells from cattle infected with Mycobacterium paratuberculosis.

Authors:  Paul M Coussens; Christopher J Colvin; Kacie Wiersma; Amy Abouzied; Sue Sipkovsky
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients.

Authors:  C Hubeau; R Le Naour; M Abély; J Hinnrasky; M Guenounou; D Gaillard; E Puchelle
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 9.  Immune system: a double-edged sword in cancer.

Authors:  Bodduluru Lakshmi Narendra; Kasala Eshvendar Reddy; Saladi Shantikumar; Sistla Ramakrishna
Journal:  Inflamm Res       Date:  2013-07-19       Impact factor: 4.575

10.  Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  Z Xing; J Wang; K Croitoru; J Wakeham
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.